The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports and stock price the company's current number of shares outstanding is 535,000,000. At the end of 2023 the company had 535,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.53 B | 0% |
2022 | 0.53 B | -4.8% |
2021 | 0.56 B | -3.27% |
2020 | 0.58 B | -2.02% |
2019 | 0.59 B | -6.61% |
2018 | 0.63 B | -12.29% |
2017 | 0.72 B | -2.43% |
2016 | 0.74 B | -1.59% |
2015 | 0.75 B | -0.92% |
2014 | 0.76 B | 0.93% |
2013 | 0.75 B | -1.18% |
2012 | 0.76 B | -10.66% |
2011 | 0.85 B | -9.34% |
2010 | 0.94 B | -6.18% |
2009 | 1.00 B | -4.83% |
2008 | 1.05 B | -2.94% |
2007 | 1.08 B | -6.37% |
2006 | 1.16 B | -5.61% |
2005 | 1.23 B | -2.77% |
2004 | 1.26 B | -1.56% |
2003 | 1.28 B | -0.96% |
2002 | 1.29 B | 23.89% |
2001 | 1.04 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,407,178,000 | 349.94% | ๐บ๐ธ USA |
![]() Pfizer PFE | 5,646,000,000 | 955.33% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 1,767,000,000 | 230.28% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 949,303,000 | 77.44% | ๐บ๐ธ USA |
![]() Biogen BIIB | 144,800,000 | -72.93% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | 1,248,000,000 | 133.27% | ๐บ๐ธ USA |
![]() Illumina ILMN | 158,000,000 | -70.47% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 2,057,000,000 | 284.49% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 2,027,500,000 | 278.97% | ๐ฌ๐ง UK |